|
Sign In to gain access to subscriptions and/or personal tools.
|
Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection
T Hayashi
Department of Medicine, Jutendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka-cho, Tagata-gun, Shizuoka 41022, Tokyo 113, Japan
S Lee
H Ogasawara
Department of Internal Medicine and Rheumatology, Tokyo 113, Japan
I Sekigawa
Department of Internal Medicine, Jutendo University Izu-Nagaoka Hospital, 1129 Nagaoka-cho, Izu-Nagaoka, Tagata-gun, Shizuoka 410-22, Japan
N Iida
Department of Medicine, Jutendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka-cho, Tagata-gun, Shizuoka 41022, Tokyo 113, Japan
Y Tomino
Department of Nephrology, Jutendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan
H Hashimoto
Department of Internal Medicine and Rheumatology, Tokyo 113, Japan
S Hirose
Department of Medicine, Jutendo University Izu-Nagaoka Hospital, 1129 Nagaoka, Izu-Nagaoka-cho, Tagata-gun, Shizuoka 41022, Tokyo 113, Japan
We report two patients with systemic lupus erythematosus (SLE) in whom cytomegalovirus (CMV) infection may have played a significant role in the exacerbation or onset of symptoms. The first patient had thrombocytopenia and the second had proteinuria. CMV infection was observed in both patients when their symptoms developed.
Key Words: systemic lupus erythematosus cytomegalovirus thrombocytopenia proteinuria viral Meningitis
Lupus, Vol. 7, No. 8,
561-564 (1998)
DOI: 10.1191/096120398678920596

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Berkun, G. Zandman-Goddard, O. Barzilai, M. Boaz, Y. Sherer, B. Larida, M. Blank, J-M. Anaya, and Y. Shoenfeld
Infectious antibodies in systemic lupus erythematosus patients
Lupus,
November 1, 2009;
18(13):
1129 - 1135.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Simard, K. Costenbader, M. Liang, E. Karlson, and M. Mittleman
Exposure to maternal smoking and incident SLE in a prospective cohort study
Lupus,
April 1, 2009;
18(5):
431 - 435.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M W Beresford, A G Cleary, J A Sills, J Couriel, and J E Davidson
Cardio-pulmonary involvement in juvenile systemic lupus erythematosus
Lupus,
February 1, 2005;
14(2):
152 - 158.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Seta, T. Shimizu, M. Nawata, R. Wada, K. Mori, I. Sekigawa, N. Iida, M. Maeda, and H. Hashimoto
A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy
Rheumatology,
September 1, 2002;
41(9):
1072 - 1073.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Zonana-Nacach, A Camargo-Coronel, P Yanez, L Sanchez, F J Jimenez-Balderas, and A Fraga
Infections in outpatients with systemic lupus erythematosus: a prospective study
Lupus,
July 1, 2001;
10(7):
505 - 510.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Bave, G. V. Alm, and L. Ronnblom
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-{alpha} Inducer
J. Immunol.,
September 15, 2000;
165(6):
3519 - 3526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ogasawara, H. Kaneko, T. Hishikawa, I. Sekigawa, Y. Takasaki, H. Hashimoto, S. Hirose, Y. Kaneko, and N. Maruyama
Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus
Rheumatology,
November 1, 1999;
38(11):
1163 - 1164.
[Full Text]
[PDF]
|
 |
|
|
|